These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23761914)

  • 1. Evidence for efficacy of a drug widely used without authorisation in multiple sclerosis: mycophenolate mofetil.
    Kira J
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):246. PubMed ID: 23761914
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil and neurological diseases.
    Vermersch P; Stojkovic T; de Seze J
    Lupus; 2005; 14 Suppl 1():s42-5. PubMed ID: 15803931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate-mofetil in the treatment of refractory multiple sclerosis.
    Ahrens N; Salama A; Haas J
    J Neurol; 2001 Aug; 248(8):713-4. PubMed ID: 11569905
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of immunosuppressive therapy for the treatment of multiple sclerosis.
    Stankiewicz JM; Kolb H; Karni A; Weiner HL
    Neurotherapeutics; 2013 Jan; 10(1):77-88. PubMed ID: 23271506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on: clinical development of mycophenolate mofetil in multiple sclerosis.
    Davies SL; Moral MA
    Drug News Perspect; 2006 Dec; 19(10):632-3. PubMed ID: 17299605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.
    Michel L; Vukusic S; De Seze J; Ducray F; Ongagna JC; Lefrère F; Jacq-Foucher M; Confavreux C; Wiertlewski S; Laplaud DA
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):279-83. PubMed ID: 23704316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil for primary biliary cirrhosis and sclerosis cholangitis?
    Altschuler EL
    Nephrol Dial Transplant; 1999 Mar; 14(3):798-9. PubMed ID: 10193850
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis.
    Herrick AL; Lunt M; Silman AJ; Denton CP
    Rheumatology (Oxford); 2010 Aug; 49(8):1607-8; author reply 1608. PubMed ID: 20427293
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil in the treatment of multiple sclerosis: a preliminary report.
    Pandit L; Mustafa S; Malli C; D'Cunha A
    Neurol India; 2014; 62(6):646-8. PubMed ID: 25591678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging treatments in multiple sclerosis: azathioprine and mofetil.
    Confavreux C; Moreau T
    Mult Scler; 1996 Jul; 1(6):379-84. PubMed ID: 9345422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of multiple sclerosis on tacrolimus plus mycophenolate mofetil after liver transplantation. Clinical improvement of multiple sclerosis in a patient requiring liver transplantation for acute liver failure following interferon-beta therapy.
    Behrbohm J; Neid M; Stölzel U; Wittekind C; Hauss JP; Tillmann HL
    Transpl Int; 2007 Dec; 20(12):1077-9. PubMed ID: 17937765
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil.
    Mogyorósi A; Lippman HR; Feldman GM
    Am J Nephrol; 2002; 22(5-6):569-72. PubMed ID: 12381961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil.
    Bell J; Ross K
    ANNA J; 1996 Aug; 23(4):409-10, 413. PubMed ID: 8900688
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.
    Karassa FB; Isenberg DA
    N Engl J Med; 2001 Feb; 344(5):382-3. PubMed ID: 11195799
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil.
    Heymann WR
    J Am Acad Dermatol; 2005 Dec; 53(6):1045-6. PubMed ID: 16310066
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycophenolate mofetil therapy.
    Kilmartin DJ; Dick AD
    Ophthalmology; 1999 Sep; 106(9):1645. PubMed ID: 10485526
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil in IgA nephropathy.
    Sepe V; Rossi N; Adamo G; Dal Canton A
    Kidney Int; 2004 Oct; 66(4):1713; author reply 1713-4. PubMed ID: 15458475
    [No Abstract]   [Full Text] [Related]  

  • 19. The muddle of mycophenolate mofetil in myasthenia.
    Benatar M; Rowland LP
    Neurology; 2008 Aug; 71(6):390-1. PubMed ID: 18678821
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
    Lankarani KB
    Aliment Pharmacol Ther; 2005 May; 21(10):1279-80; author reply 1280. PubMed ID: 15882250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.